Critical Outcome Technologies, Inc. (OTC: COTQF) is engaged in disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. COTI is focused on the discovery and pre-clinical development of small molecules for the treatment of serious diseases for which current therapy is either lacking or ineffective. The company’s strategy is to partner with pharmaceutical, biotechnology and therapeutics companies at an early stage to augment their pipelines and accelerate innovation.  For more information, visit the company’s website at www.criticaloutcome.com